Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma.

Fu, Zhiying; Zhu, Jun; Zheng, Wen; Liu, Weiping; Ying, Zhitao; Xie, Yan; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Ding, Ning; Song, Yuqin

Fu, Zhiying; Zhu, Jun; Zheng, Wen; Liu, Weiping; Ying, Zhitao; Xie, Yan; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Ding, Ning; Song, Yuqin.

Afiliación

Song Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing 100142, China. songyuqin622@sina.com.

Cancer Cell Int ; 14(1): 5, 2014 Jan 18.

Article en En | MEDLINE | ID: mdl-24438119

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2014 Tipo del documento: Article